Cue Biopharma Inc.
(CUE)
undefined
undefined%
At close: undefined
0.97
3.18%
After-hours Dec 13, 2024, 07:39 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Cash & Equivalents | 48.51M | 51.61M | 64.37M | 74.87M | 44.29M | 20.80M | 63.53M | 14.93M | 6.41M |
Short-Term Investments | - | 24.67M | - | 10.00M | 15.12M | 18.41M | 50.07K | 50.03K | 50.00K |
Long-Term Investments | 151.00K | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K | - | - | - |
Other Long-Term Assets | 2.81M | 3.24M | 2.86M | 2.97M | 3.40M | 1.82M | 23.28K | 117.00K | 98.50K |
Receivables | 1.70M | 57.25K | 3.14M | 1.42M | 754.90K | - | - | - | - |
Inventory | - | 1.00 | 1.00 | - | 15.12M | - | 225.50K | - | - |
Other Current Assets | 1.24M | 1.68M | 1.83M | 2.48M | 1.72M | 1.40M | 1.31M | 162.40K | 51.45K |
Total Current Assets | 51.45M | 77.19M | 68.47M | 87.53M | 61.02M | 40.61M | 65.07M | 15.14M | 6.51M |
Property-Plant & Equipment | 7.12M | 10.70M | 11.92M | 8.88M | 7.18M | 2.78M | 1.69M | 1.02M | 709.47K |
Goodwill & Intangibles | - | - | - | - | 11.67K | - | 175.00K | - | - |
Total Long-Term Assets | 10.08M | 14.10M | 14.93M | 12.01M | 10.58M | 4.75M | 1.89M | 1.14M | 807.97K |
Total Assets | 61.53M | 91.28M | 83.40M | 99.53M | 71.61M | 45.36M | 66.95M | 16.28M | 7.31M |
Account Payables | 3.50M | 2.73M | 2.59M | 2.07M | 882.67K | 2.04M | 1.33M | 523.81K | 139.63K |
Deferred Revenue | 2.11M | - | 645.35K | 6.68M | 4.10M | 2.01M | 623.85K | - | - |
Short-Term Debt | 7.33M | 5.26M | 9.86M | 9.55M | 8.90M | - | - | - | - |
Other Current Liabilities | 4.14M | 3.55M | 333.63K | -1.99M | -2.22M | 2.17M | 4.02M | 543.80K | 202.57K |
Total Current Liabilities | 17.08M | 11.55M | 12.79M | 16.32M | 11.66M | 6.22M | 5.35M | 1.07M | 342.20K |
Long-Term Debt | 7.36M | 14.06B | 5.12M | 2.37M | 1.35M | - | - | - | - |
Other Long-Term Liabilities | - | -14.04B | - | - | - | - | - | 36.36K | 34.09K |
Total Long-Term Liabilities | 7.36M | 14.05M | 5.12M | 4.31M | 5.37M | 5.17M | - | 36.36K | 34.09K |
Total Liabilities | 24.45M | 25.60M | 17.91M | 20.62M | 17.02M | 11.39M | 5.35M | 1.10M | 376.30K |
Total Debt | 14.70M | 19.32M | 10.05M | 7.15M | 5.80M | - | 2.50M | - | - |
Common Stock | 47.00K | 43.04K | 32.20K | 30.35K | 26.56K | 20.70K | 20.13K | 10.64K | 7.35K |
Retained Earnings | -301.19M | -250.46M | -197.45M | -153.29M | -108.50M | -71.80M | -32.82M | -9.59M | -1.93M |
Comprehensive Income | - | -95.87K | -0.00 | 7.13K | -10.32K | -10.96K | -661.15K | -246.90K | -44.81K |
Shareholders Equity | 37.09M | 65.68M | 65.49M | 78.91M | 54.58M | 33.97M | 61.61M | 15.17M | 6.94M |
Total Investments | 151.00K | 24.67M | 150.00K | 10.00M | 15.12M | 18.41M | 50.07K | 50.03K | 50.00K |